Parathyroid hormone (PTH) is an essential biomarker of calcium/phosphate metabolism. Secondary hyperparathyroidism linked to vitamin D deficiency is largely described. Yet, only few studies are evaluating its prevalence in children. In Belgium, clinicians are generally advising a vitamin D supplementation at high doses in all children under the age of 2 years. From 2 to 6 years old, this supplementation is progressively decreased. In this study, we report PTH levels according to the vitamin D status in large cohort of 1200 Belgian children.
In this study realized in a large cohort of 1200 Belgian children, we show the existence of secondary hyperparathyroidism linked to Vitamin D deficiency in children. In children with optimal vitamin D status, we observe a higher PTH level during teenage years, probably linked to higher calcium needs for bone formation. Those results further highlight the importance of taking into account 25-hydroxyvitaminD status to establish pediatric PTH reference values. PTH and 25 PTH and 25 PTH and 25----OHVTD levels according to age and gender OHVTD levels according to age and gender OHVTD levels according to age and gender OHVTD levels according to age and gender: : : : PTH levels inversely mirrored 25-OHVTD concentrations for all age and gender subgroups. PTH and 25-OHVTD levels in girls according to age are presented for girls (first graph) and for boys (second graph). PTH levels in children harboring a 25 PTH levels in children harboring a 25 PTH levels in children harboring a 25 PTH levels in children harboring a 25----OHVTD above 20 ng/mL: OHVTD above 20 ng/mL: OHVTD above 20 ng/mL: OHVTD above 20 ng/mL: We observed a PTH peak at puberty for girls of 11 to 13 years old whereas this peak started at 13 years old for boys. 
